UTHR stock news

UTHR stock news. Deduplicated factual headlines, scored for importance, with entity sentiment and the sectors, countries, and asset classes affected. Updates open into the storyline.

See the full wire

20 wire items

2026-10-28 16:07:42 UTC#530388newconfirmednews

United Therapeutics receives FDA clearance to initiate Phase 1 trial for treprostinil-iloprost SMI

seeking alphaimportance 0.40trust 0.70United Therapeutics Corporation +0.40treprostinil-iloprost SMI +0.40

2026-10-22 16:21:53 UTC#501280newconfirmednews

RBC Capital maintains Outperform rating on United Therapeutics, sets $697 price target

tradingviewimportance 0.40trust 0.70United Therapeutics Corporation +0.50RBC Capital Markets, LLC 0Tyvaso DPI +0.40+1 entities

2026-10-19 14:26:58 UTC#481163newconfirmednews

Leerink Partners maintains Outperform rating on United Therapeutics, sets $725 price target

tradingviewimportance 0.40trust 0.60Leerink Partners 0United Therapeutics Corporation +0.40Liquidia Corporation 0+2 entities

2026-10-19 11:33:02 UTC#480014newconfirmedpress release

United Therapeutics receives FDA clearance for SUMMIT Phase 3 trial of Treprostinil SMI in PH-COPD

reutersimportance 0.50trust 0.90United Therapeutics Corporation +0.40Food and Drug Administration +0.30SUMMIT +0.30

2026-10-14 14:53:16 UTC#459899duplicateconfirmednews

Liquidia shares rise over 30% following United Therapeutics settlement; BTIG upgrades stock

seeking alphaimportance 0.30trust 0.60Liquidia Corporation +0.60United Therapeutics Corporation -0.40BTIG, LLC +0.40

2026-10-14 14:24:00 UTC#459761duplicateconfirmednews

Liquidia shares surge 30% following $380M patent settlement with United Therapeutics

dow_jonesimportance 0.30trust 0.80Liquidia Corporation +0.80United Therapeutics Corporation -0.20Yutrepia +0.80

2026-10-14 14:22:00 UTC#459718duplicateconfirmednews

Liquidia shares rise 29% following $380.7M patent settlement with United Therapeutics

dow_jonesimportance 0.30trust 0.80Liquidia Corporation +0.80United Therapeutics Corporation -0.40Tyvaso 0+1 entities

2026-10-14 12:46:08 UTC#459041duplicateconfirmednews

Liquidia shares jump 37% following $380.7M settlement with United Therapeutics to resolve Yutrepia litigation

reutersimportance 0.30trust 0.90Liquidia Corporation +0.80United Therapeutics Corporation -0.20Yutrepia +0.80+2 entities

2026-10-14 11:52:58 UTC#458667duplicateconfirmednews

Liquidia shares rise following $381 million settlement with United Therapeutics to resolve Yutrepia litigation

reutersimportance 0.30trust 0.90Liquidia Corporation +0.80United Therapeutics Corporation -0.50

2026-10-14 11:50:13 UTC#458623duplicateconfirmednews

Liquidia shares rise following $381 million settlement with United Therapeutics to resolve Yutrepia litigation

reutersimportance 0.30trust 0.90Liquidia Corporation +0.60United Therapeutics Corporation -0.40Yutrepia +0.40+1 entities

2026-10-14 11:03:00 UTC#458294updateconfirmednews

Liquidia to pay United Therapeutics $330.4M to settle litigation and remove PH-ILD indication from Yutrepia label

tradingviewimportance 0.60trust 0.70United Therapeutics Corporation +0.40Liquidia Corporation -0.40Yutrepia -0.50+1 entities

2026-10-14 10:13:00 UTC#457988updateconfirmednews

Liquidia settles United Therapeutics litigation for $320.4M, removes PH-ILD indication for Yutrepia

tradingviewimportance 0.60trust 0.80Liquidia Corporation +0.40United Therapeutics Corporation -0.40Yutrepia +0.20+2 entities

2026-10-14 07:00:00 UTC#457120duplicateconfirmednews

Liquidia reports $222.7M in preliminary Q3 YUTREPIA sales following $380.7M United Therapeutics settlement

tradingviewimportance 0.40trust 0.60Liquidia Corporation +0.80United Therapeutics Corporation -0.40YUTREPIA +0.80

2026-10-14 05:06:13 UTC#456599duplicateconfirmednews

Liquidia shares surge 42% following $380.7M settlement with United Therapeutics to resolve YUTREPIA litigation

seeking alphaimportance 0.30trust 0.70Liquidia Corporation +0.80United Therapeutics Corporation -0.40

2026-10-14 01:23:02 UTC#455915duplicateconfirmednews

Liquidia settles litigation with United Therapeutics for $380.7M, securing YUTREPIA access

Open sourceimportance 0.30trust 0.70Liquidia Corporation +0.60United Therapeutics Corporation -0.20YUTREPIA +0.60+2 entities

2026-10-13 22:30:00 UTC#455489duplicateconfirmednews

Liquidia to pay $380.7M to settle all litigation with United Therapeutics, securing Yutrepia access

dow_jonesimportance 0.30trust 0.90Liquidia Corporation +0.60United Therapeutics Corporation -0.40Yutrepia +0.50

2026-10-13 21:50:41 UTC#455337newconfirmedpress release

Liquidia settles all litigation with United Therapeutics for $380.7M, securing Yutrepia commercialization

reutersimportance 0.70trust 0.90Liquidia Corporation +0.60United Therapeutics Corporation -0.40Yutrepia +0.60

2026-10-08 15:08:00 UTC#433447newconfirmednews

RBC Capital maintains United Therapeutics at Outperform, raises price target to $708 from $677

dow_jonesimportance 0.30trust 0.70United Therapeutics Corporation +0.40RBC Capital Markets 0

2026-10-07 15:00:35 UTC#426610newconfirmednews

United Therapeutics wins appeal against Sandoz antitrust claims regarding Remodulin, MLex reports

mleximportance 0.50trust 0.80United Therapeutics Corporation +0.50Sandoz Group AG -0.50Remodulin 0

2026-10-01 16:07:03 UTC#400134newconfirmednews

Liquidia downgraded to Neutral at BTIG following adverse patent ruling against United Therapeutics

seeking alphaimportance 0.40trust 0.70Liquidia Corporation -0.50United Therapeutics Corporation +0.50BTIG, LLC -0.30